Dr Zoran Gluvić Internista endokrinolog

dr Zoran Gluvic


Radno iskustvo:

Stručni radovi:

Gluvic Z, Sudar E, Tica J, Jovanovic A, Zafirovic S, Tomasevic R, Isenovic ER. Effects of Levothyroxine replacement on parameters of metabolic syndrome and atherosclerosis in hypothyroid patients: a prospective pilot study. Int J Endocrinol 2015; 215: 1-9. [M23, IF 1.515]

Obradovic M, Gluvic Z, Sudar-Milovanovic E, Panic A, Trebaljevac J, Bajic V, Zarkovic M, Isenovic ER. Nitric oxide as a marker for levothyroxine therapy in subclinical hypothyroid patients. Curr Vasc Pharmacol 2016; 14(3): 266-70. [M21, IF 2.966]

Gluvic Z, Zaric B, Resanovic I, Obradovic M, Mitrovic A, Radak Dj, Isenovic ER. Link between metabolic syndrome and insulin resistance. Curr Vasc               Pharmacol 2017; 15(1): 30-9. [M21, IF 2.966]

Gluvic ZM, Sudar-Milovanovic EM, Samardzic VS, Obradovic MM, Jevremovic DP, Radenkovic SP, Isenovic ER. Serum nitric oxide levels correlate with quality of life questionnaires scores of hypothyroid females. Medical Hypotheses 2019; 131: 109299 [M22; IF 1.322]

Gluvic Z, Obradovic M, Lackovic M, Samardzic V, Tica Jevtic J, Essack M, Bajic V, Isenovic, ER. HbA1C as a marker of retrograde glycaemic control in diabetes patient with co-existed beta-thalassaemia: A case report and a literature review. J Clin Pharm Therap 2019;  doi: 10.1111/jcpt.13073. [Epub ahead of print][M22; IF 2.167]

Resanović I, Gluvić Z, Zarić B, Sudar-Milovanović E, Vučić V, Arsić A, Nedić O, Šunderić M, Gligorijević N, Milačić D, Isenović ER. Effect of hyperbaric oxygen therapy on the fatty acid composition and IGFBP-1 in insulin-dependent diabetes mellitus adult patients: a pilot study. Can J Diabetes 2020; 44(1): 22-9. DOI: https://doi.org/10.1016/j.jcjd.2019.04.018 [M21; IF 2.193]

Gluvic ZM, Obradovic MM, Sudar-Milovanovic EM, Zafirovic SS, Radak DjJ, Essack MM, Bajic VB, Takashi G, Isenovic ER. Regulation of nitric oxide production in hypothyroidism. Biomed Pharmacother 2020; 124: 109881. [M21; IF 3.743]